Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Radiation's hidden cost: new study tracks financial toxicity in cancer patients

NCT ID NCT07175350

Knowledge-focused Sponsor: Valerio Nardone Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will measure financial toxicity—the financial burden of cancer treatment—in 1000 patients receiving radiotherapy. Participants will fill out questionnaires about their expenses and quality of life before, during, and after treatment. The goal is to understand how radiation therapy affects patients' finances and to identify those who may need extra support.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help identify cancer patients at risk of financial hardship during radiotherapy, leading to better support programs.
What could go wrong
This is an observational study, so it does not test a treatment. The results may not apply to all cancer types or healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Oncologic patients undergoing radiotherapy

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients older than 18 years of age. Histological diagnosis of malignancy for which the patient requires radiotherapy treatment. Exclusion Criteria: * Patient refusal to complete the questionnaire.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Oncologic diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer Financial Stress neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Oncologic diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • .C. Radioterapia - INT G. Pascale

    RECRUITING

    Naples, Italy

  • AOU "L. Vanvitelli" - UOC Radioterapia

    RECRUITING

    Naples, 80131, Italy

  • Radioterapia Oncologica - Ospedale Mons. Dimiccoli

    RECRUITING

    Barletta, Italy

  • Radioterapia Oncologica, IRCCS-CROB

    RECRUITING

    Potenza, 85028, Italy

  • Radioterapia oncologica - Ospedale "Vito Fazzi" -

    RECRUITING

    Lecce, Italy

  • UOC Radioterapia - Fondazione Policlinico A. Gemelli

    RECRUITING

    Roma, Italy

  • Unità di Radioterapia - Responsible Research Hospital

    RECRUITING

    Campobasso, 80017, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.